#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0009] In a further configuration, the erythrocyte concentrate is returned to the patient through the plasma filter with renewed separation of a further plasma fraction.
#Text=[0010] Although double fractionation of plasma is performed here, the erythrocyte concentrate is returned to the blood donor again directly without interim storage.
#Text=[0011] EP 349 188 describes a method for separating blood into blood components, and a separator unit for recovering these blood components.
1-1	0-1	[	_	_	
1-2	1-5	0009	_	_	
1-3	5-6	]	_	_	
1-4	7-9	In	_	_	
1-5	10-11	a	_	_	
1-6	12-19	further	_	_	
1-7	20-33	configuration	_	_	
1-8	33-34	,	_	_	
1-9	35-38	the	_	_	
1-10	39-50	erythrocyte	_	_	
1-11	51-62	concentrate	_	_	
1-12	63-65	is	_	_	
1-13	66-74	returned	_	_	
1-14	75-77	to	_	_	
1-15	78-81	the	_	_	
1-16	82-89	patient	_	_	
1-17	90-97	through	_	_	
1-18	98-101	the	_	_	
1-19	102-108	plasma	_	_	
1-20	109-115	filter	_	_	
1-21	116-120	with	_	_	
1-22	121-128	renewed	_	_	
1-23	129-139	separation	_	_	
1-24	140-142	of	_	_	
1-25	143-144	a	_	_	
1-26	145-152	further	_	_	
1-27	153-159	plasma	_	_	
1-28	160-168	fraction	_	_	
1-29	168-169	.	_	_	
1-30	170-171	[	_	_	
1-31	171-175	0010	_	_	
1-32	175-176	]	_	_	
1-33	177-185	Although	_	_	
1-34	186-192	double	_	_	
1-35	193-206	fractionation	_	_	
1-36	207-209	of	_	_	
1-37	210-216	plasma	_	_	
1-38	217-219	is	_	_	
1-39	220-229	performed	_	_	
1-40	230-234	here	_	_	
1-41	234-235	,	_	_	
1-42	236-239	the	_	_	
1-43	240-251	erythrocyte	_	_	
1-44	252-263	concentrate	_	_	
1-45	264-266	is	_	_	
1-46	267-275	returned	_	_	
1-47	276-278	to	_	_	
1-48	279-282	the	_	_	
1-49	283-288	blood	_	_	
1-50	289-294	donor	_	_	
1-51	295-300	again	_	_	
1-52	301-309	directly	_	_	
1-53	310-317	without	_	_	
1-54	318-325	interim	_	_	
1-55	326-333	storage	_	_	
1-56	333-334	.	_	_	
1-57	335-336	[	_	_	
1-58	336-340	0011	_	_	
1-59	340-341	]	_	_	
1-60	342-344	EP	_	_	
1-61	345-348	349	_	_	
1-62	349-352	188	_	_	
1-63	353-362	describes	_	_	
1-64	363-364	a	*[1]	2-3[2_1]	
1-65	365-371	method	*[1]	_	
1-66	372-375	for	*[1]	_	
1-67	376-386	separating	*[1]	_	
1-68	387-392	blood	*[1]	_	
1-69	393-397	into	*[1]	_	
1-70	398-403	blood	*[1]	_	
1-71	404-414	components	*[1]	_	
1-72	414-415	,	_	_	
1-73	416-419	and	_	_	
1-74	420-421	a	_	_	
1-75	422-431	separator	_	_	
1-76	432-436	unit	_	_	
1-77	437-440	for	_	_	
1-78	441-451	recovering	_	_	
1-79	452-457	these	_	_	
1-80	458-463	blood	_	_	
1-81	464-474	components	_	_	
1-82	474-475	.	_	_	

#Text=According to this method, blood is first conveyed from a whole-blood container through a filter which removes leukocytes and also blood platelets.
2-1	476-485	According	_	_	
2-2	486-488	to	_	_	
2-3	489-493	this	*[2]	_	
2-4	494-500	method	*[2]	_	
2-5	500-501	,	_	_	
2-6	502-507	blood	_	_	
2-7	508-510	is	_	_	
2-8	511-516	first	_	_	
2-9	517-525	conveyed	_	_	
2-10	526-530	from	_	_	
2-11	531-532	a	_	_	
2-12	533-544	whole-blood	_	_	
2-13	545-554	container	_	_	
2-14	555-562	through	_	_	
2-15	563-564	a	_	_	
2-16	565-571	filter	_	_	
2-17	572-577	which	_	_	
2-18	578-585	removes	_	_	
2-19	586-596	leukocytes	_	_	
2-20	597-600	and	_	_	
2-21	601-605	also	_	_	
2-22	606-611	blood	_	_	
2-23	612-621	platelets	_	_	
2-24	621-622	.	_	_	

#Text=The filtered blood is then collected in a primary bag which is then subjected to centrifugation to divide the blood up into a plasma fraction and an erythrocyte concentrate.
3-1	623-626	The	_	_	
3-2	627-635	filtered	_	_	
3-3	636-641	blood	_	_	
3-4	642-644	is	_	_	
3-5	645-649	then	_	_	
3-6	650-659	collected	_	_	
3-7	660-662	in	_	_	
3-8	663-664	a	_	_	
3-9	665-672	primary	_	_	
3-10	673-676	bag	_	_	
3-11	677-682	which	_	_	
3-12	683-685	is	_	_	
3-13	686-690	then	_	_	
3-14	691-700	subjected	_	_	
3-15	701-703	to	_	_	
3-16	704-718	centrifugation	_	_	
3-17	719-721	to	_	_	
3-18	722-728	divide	_	_	
3-19	729-732	the	_	_	
3-20	733-738	blood	_	_	
3-21	739-741	up	_	_	
3-22	742-746	into	_	_	
3-23	747-748	a	_	_	
3-24	749-755	plasma	_	_	
3-25	756-764	fraction	_	_	
3-26	765-768	and	_	_	
3-27	769-771	an	_	_	
3-28	772-783	erythrocyte	_	_	
3-29	784-795	concentrate	_	_	
3-30	795-796	.	_	_	

#Text=The plasma is conveyed through a plasma line into a further plasma bag.
#Text=[0012] As has already been explained above, this method is technically complex because of the use of a centrifuge.
4-1	797-800	The	*[3]	4-25[4_3]	
4-2	801-807	plasma	*[3]	_	
4-3	808-810	is	*[3]	_	
4-4	811-819	conveyed	*[3]	_	
4-5	820-827	through	*[3]	_	
4-6	828-829	a	*[3]	_	
4-7	830-836	plasma	*[3]	_	
4-8	837-841	line	*[3]	_	
4-9	842-846	into	*[3]	_	
4-10	847-848	a	*[3]	_	
4-11	849-856	further	*[3]	_	
4-12	857-863	plasma	*[3]	_	
4-13	864-867	bag	*[3]	_	
4-14	867-868	.	*[3]	_	
4-15	869-870	[	_	_	
4-16	870-874	0012	_	_	
4-17	874-875	]	_	_	
4-18	876-878	As	_	_	
4-19	879-882	has	_	_	
4-20	883-890	already	_	_	
4-21	891-895	been	_	_	
4-22	896-905	explained	_	_	
4-23	906-911	above	_	_	
4-24	911-912	,	_	_	
4-25	913-917	this	*[4]	_	
4-26	918-924	method	*[4]	_	
4-27	925-927	is	_	_	
4-28	928-939	technically	_	_	
4-29	940-947	complex	_	_	
4-30	948-955	because	_	_	
4-31	956-958	of	_	_	
4-32	959-962	the	_	_	
4-33	963-966	use	_	_	
4-34	967-969	of	_	_	
4-35	970-971	a	_	_	
4-36	972-982	centrifuge	_	_	
4-37	982-983	.	_	_	

#Text=Moreover, the plasma cannot be separated completely, because there may otherwise be a danger of mixing with erythrocytes.
#Text=[0013] U.S.
5-1	984-992	Moreover	_	_	
5-2	992-993	,	_	_	
5-3	994-997	the	_	_	
5-4	998-1004	plasma	_	_	
5-5	1005-1011	cannot	_	_	
5-6	1012-1014	be	_	_	
5-7	1015-1024	separated	_	_	
5-8	1025-1035	completely	_	_	
5-9	1035-1036	,	_	_	
5-10	1037-1044	because	_	_	
5-11	1045-1050	there	_	_	
5-12	1051-1054	may	_	_	
5-13	1055-1064	otherwise	_	_	
5-14	1065-1067	be	_	_	
5-15	1068-1069	a	_	_	
5-16	1070-1076	danger	_	_	
5-17	1077-1079	of	_	_	
5-18	1080-1086	mixing	_	_	
5-19	1087-1091	with	_	_	
5-20	1092-1104	erythrocytes	_	_	
5-21	1104-1105	.	_	_	
5-22	1106-1107	[	_	_	
5-23	1107-1111	0013	_	_	
5-24	1111-1112	]	_	_	
5-25	1113-1116	U.S	_	_	
5-26	1116-1117	.	_	_	

#Text=Pat.
6-1	1118-1121	Pat	_	_	
6-2	1121-1122	.	_	_	

#Text=No. 5,527,472 likewise describes a closed system for separation of whole-blood constituents by means of centrifugation.
7-1	1123-1125	No	*[5]	8-2[6_5]	
7-2	1125-1126	.	*[5]	_	
7-3	1127-1136	5,527,472	*[5]	_	
7-4	1137-1145	likewise	*[5]	_	
7-5	1146-1155	describes	*[5]	_	
7-6	1156-1157	a	*[5]	_	
7-7	1158-1164	closed	*[5]	_	
7-8	1165-1171	system	*[5]	_	
7-9	1172-1175	for	*[5]	_	
7-10	1176-1186	separation	*[5]	_	
7-11	1187-1189	of	*[5]	_	
7-12	1190-1201	whole-blood	*[5]	_	
7-13	1202-1214	constituents	*[5]	_	
7-14	1215-1217	by	*[5]	_	
7-15	1218-1223	means	*[5]	_	
7-16	1224-1226	of	*[5]	_	
7-17	1227-1241	centrifugation	*[5]	_	
7-18	1241-1242	.	*[5]	_	

#Text=In this method, the centrifugation initially takes place in a first bag with division into plasma and an erythrocyte concentrate, to which a substitute solution is then mixed.
8-1	1243-1245	In	_	_	
8-2	1246-1250	this	*[6]	_	
8-3	1251-1257	method	*[6]	_	
8-4	1257-1258	,	_	_	
8-5	1259-1262	the	_	_	
8-6	1263-1277	centrifugation	_	_	
8-7	1278-1287	initially	_	_	
8-8	1288-1293	takes	_	_	
8-9	1294-1299	place	_	_	
8-10	1300-1302	in	_	_	
8-11	1303-1304	a	_	_	
8-12	1305-1310	first	_	_	
8-13	1311-1314	bag	_	_	
8-14	1315-1319	with	_	_	
8-15	1320-1328	division	_	_	
8-16	1329-1333	into	_	_	
8-17	1334-1340	plasma	_	_	
8-18	1341-1344	and	_	_	
8-19	1345-1347	an	_	_	
8-20	1348-1359	erythrocyte	_	_	
8-21	1360-1371	concentrate	_	_	
8-22	1371-1372	,	_	_	
8-23	1373-1375	to	_	_	
8-24	1376-1381	which	_	_	
8-25	1382-1383	a	_	_	
8-26	1384-1394	substitute	_	_	
8-27	1395-1403	solution	_	_	
8-28	1404-1406	is	_	_	
8-29	1407-1411	then	_	_	
8-30	1412-1417	mixed	_	_	
8-31	1417-1418	.	_	_	

#Text=This mixture is then freed of leukocytes in a leukocyte-removing filter, so that an erythrocyte concentrate with substitute solution is obtained, but which still contains a high proportion of plasma.
9-1	1419-1423	This	_	_	
9-2	1424-1431	mixture	_	_	
9-3	1432-1434	is	_	_	
9-4	1435-1439	then	_	_	
9-5	1440-1445	freed	_	_	
9-6	1446-1448	of	_	_	
9-7	1449-1459	leukocytes	_	_	
9-8	1460-1462	in	_	_	
9-9	1463-1464	a	_	_	
9-10	1465-1483	leukocyte-removing	_	_	
9-11	1484-1490	filter	_	_	
9-12	1490-1491	,	_	_	
9-13	1492-1494	so	_	_	
9-14	1495-1499	that	_	_	
9-15	1500-1502	an	_	_	
9-16	1503-1514	erythrocyte	_	_	
9-17	1515-1526	concentrate	_	_	
9-18	1527-1531	with	_	_	
9-19	1532-1542	substitute	_	_	
9-20	1543-1551	solution	_	_	
9-21	1552-1554	is	_	_	
9-22	1555-1563	obtained	_	_	
9-23	1563-1564	,	_	_	
9-24	1565-1568	but	_	_	
9-25	1569-1574	which	_	_	
9-26	1575-1580	still	_	_	
9-27	1581-1589	contains	_	_	
9-28	1590-1591	a	_	_	
9-29	1592-1596	high	_	_	
9-30	1597-1607	proportion	_	_	
9-31	1608-1610	of	_	_	
9-32	1611-1617	plasma	_	_	
9-33	1617-1618	.	_	_	
